Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Saskatchewan

$27,000.00

Investigating the function of microglia in limiting OxPC-mediated neurodegeneration in the context of TREM2 expression.

EF 2024-25

Résumé
Multiple sclerosis (MS) is a disease characterized with progressive loss of brain tissue. Although the mechanisms which drive MS progression are not fully understood, we recently found that oxidized phosphatidylcholine (OxPC) are harmful lipids which accumulate in MS brain lesions and are capable of driving neurodegeneration. Thus, understanding how cells in the brain respond to and neutralize OxPC may lead to discoveries important for halting MS progression. Microglia are resident immune cells of the brain, and we previously found their ability to help OxPC clearance requires a cell surface molecule called triggering receptor on myeloid cells 2 (TREM2). However, the signaling mechanisms of how TREM2 mediates microglia activity in response to OxPC remains unknown. Since TREM2 deficiency worsens OxPC mediated neurodegeneration, I hypothesize that TREM2 signaling is important for microglia to recognize and clear OxPC and to prevent OxPC mediated neurodegeneration. To test this hypothesis, I will compare how normal and TREM2 deficient microglia differentially respond to OxPC treatment using molecular and cellular assays including microscopy, RNA sequencing, and protein quantification. To study how microglial TREM2 expression impacts MS relevant neurodegeneration in vivo, I will deposit OxPC into spinal cord and brain of normal and TREM2 deficient and compare the severity of both acute and chronic OxPC mediated neurodegeneration. Collectively, these studies will provide new knowledge in how OxPC mediated TREM2 signaling modulates microglial reactivity to OxPC and how TREM2 expressing microglia can modulate the outcome of chronic neurodegeneration and MS.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529939
Name
Park Jian
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the function of microglia in limiting OxPC-mediated neurodegeneration in the context of TREM2 expression.
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain; Central Nervous System; Inflammation; Macrophages; Microglia; Multiple Sclerosis; Neurodegeneration; Neurons; Oxidized Phosphatidylcholine; Triggering Receptor Expressed On Myeloid Cells 2
Abstract
Multiple sclerosis (MS) is a disease characterized with progressive loss of brain tissue. Although the mechanisms which drive MS progression are not fully understood, we recently found that oxidized phosphatidylcholine (OxPC) are harmful lipids which accumulate in MS brain lesions and are capable of driving neurodegeneration. Thus, understanding how cells in the brain respond to and neutralize OxPC may lead to discoveries important for halting MS progression. Microglia are resident immune cells of the brain, and we previously found their ability to help OxPC clearance requires a cell surface molecule called triggering receptor on myeloid cells 2 (TREM2). However, the signaling mechanisms of how TREM2 mediates microglia activity in response to OxPC remains unknown. Since TREM2 deficiency worsens OxPC mediated neurodegeneration, I hypothesize that TREM2 signaling is important for microglia to recognize and clear OxPC and to prevent OxPC mediated neurodegeneration. To test this hypothesis, I will compare how normal and TREM2 deficient microglia differentially respond to OxPC treatment using molecular and cellular assays including microscopy, RNA sequencing, and protein quantification. To study how microglial TREM2 expression impacts MS relevant neurodegeneration in vivo, I will deposit OxPC into spinal cord and brain of normal and TREM2 deficient and compare the severity of both acute and chronic OxPC mediated neurodegeneration. Collectively, these studies will provide new knowledge in how OxPC mediated TREM2 signaling modulates microglial reactivity to OxPC and how TREM2 expressing microglia can modulate the outcome of chronic neurodegeneration and MS.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Jian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~